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It has  been shown  recently that  high  metastatic tumor lines can  be converted to 
low metastatic ones by mutagenization and selection for resistance to toxic concentra- 
tions of the lectin wheat germ agglutinin (1-3).  Lectin-resistant variants were found 
to  differ  from  the  parental  lines  and  respective revertants  in  terminal  cell-surface 
carbohydrates.  Here  we  describe  for  the  first  time  a  drug-independent  selection 
procedure for the isolation of a low metastatic variant type cell from a high metastatic 
tumor  line.  The  method  is  based  on  the  selection of plastic-adherent cells from  a 
suspension culture of highly malignant cells. Similar to the above situation, plastic- 
adherent low-metastatic variant cells were found to differ from the parental cells and 
from metastatic revertants in terminal cell surface carbohydrates. The importance of 
terminal carbohydrates, in particular of sialic acid, for cell-surface adhesiveness and 
metastatic potential will be discussed. 
Materials  and  Methods 
Tumor Lines.  Eb  is the  Heidelberg subline of the  methylcholanthrene A-induced T  cell 
lymphoma L5178Y of DBA/2 mice and ESb is a spontaneous high metastatic variant thereof 
(4). Details of these cells have been described elsewhere (for a review see ref. 5). 
Selection of  a Plastic-adherent Variant.  Both tumor lines Eb and ESb grow in suspension culture 
(6). A strongly plastic-adherent  variant (ESb-M) was isolated from the ESb cells by continuously 
selecting the adherent subpopulation from the suspension cultures over a  period of 2 mo and 
>20 selection steps. ESb-M cells which were released into suspension from monolayer cultures 
grown to confluency were taken for analysis. 
Flow Cytofluorography.  Immunofluorescent staining was carried out by incubating 2  ×  106 
cells with appropriately diluted fluorescein isothiocyanate- (FITC) conjugated lectins for 45 
rain on ice. The reaction was carried out in saline containing 1 mM Mg and Ca salts. Flow 
cytofluorographic analysis was performed on an  Ortho H-50 cell sorter (Ortho Instruments, 
Westwood, MA). Fluorescence gains were kept at constant setting for each lectin analyzed. Cell 
surface differentiation antigens were determined by indirect immunofluorescenceand cytofluo- 
rography as described (7). 
Isolation of Tumor Cells from  Organs.  Spleen and brain of ESb-M tumor bearing mice were 
removed 40 d  after tumor cell inoculation and pressed through a  fine nylon mesh. The cells 
were suspended and cultured in the appropriate tissue culture medium (4). 
Results 
When inoculated into syngeneic DBA/2 mice, the plastic-adherent ESb-M variant 
type cells were found  to be  tumorigenic but  not  metastatic. The survival curves of 
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mice inoculated  subcutaneously with Eb, ESb, or ESb-M  tumor cells are shown  in 
Fig.  1. ESb-tumor bearing mice died after 10-12 d with a small, just palpable tumor 
and  widespread  internal  metastases. In  contrast,  ESb-M  tumor-bearing mice lived 
more than four times as long, developed large locally growing tumors (2-4 cm diam), 
and died without overt metastases. 
ESb-M cells were found to have lost also their capacity to form artificial metastases 
after intravenous inoculation. Animals survived inocula of l0  G and even  107 ESb-M 
type cells, whereas they died  from intravenous inocula of <10  ESb-type cells. This 
surprising in  vivo finding  raised  the  question  as  to whether  ESb-M  cells were still 
ESb-type cells. We therefore examined ESb-M cells for the expression of cell-surface 
markers that can discriminate between Eb and ESb type cells (4,  5,  7).  ESb-M cells 
were found to be Thy-l-, Lyt-1  +, Lyt-2-, Fc receptor-positive and possessed the ESb- 
type tumor antigen  (TATAEsb) (Table I) thus showing a  similar phenotype as ESb 
cells. 
We then performed a  biochemical analysis of cell-surface molecules to look for a 
structural  basis  of  the  altered  biological  behaviour  of  ESb-M  cells.  Cell-surface 
molecules labeled either by lactoperoxidase-catalyzed iodination or by the galactose 
oxidase/NaBaH4 technique  and  analyzed subsequently  by sodium  dodecyl  sulfate- 
polyacrylamide gel electrophoresis were found to be similar to those of ESb but not 
of Eb-type cells (data not shown).  Differences between ESb  and  ESb-M cells were, 
however, noted in the expression of lectin-binding sites. This was assessed by staining 
the cells with various FITC-conjugated lectins and analysis by flow cytofluorography. 
The results are shown in Fig. 2. The low metastatic variant line ESb-M reacted with 
Vicia villosa  (VV) and soybean agglutinin (SBA) lectin, which recognize preferentially 
terminal N-acetylgalactosamine (Gal-NAc) residues.  ESb-M cells were also reactive 
with peanut  agglutinin  (PNA)  possessing a  strong affinity for terminal  D-Galactose 
(D-Gal) residues. The binding of these lectins could be specifically inhibited  by the 
respective free sugars. 
In contrast,  the  high  metastatic ESb-type cells were only poorly  labeled by the 
above lectins. The staining with concanavalin A  (Con A) which reacts with the core 
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Fie.  1.  Mortality curves of DBA/2 mice (10/group) inoculated subcutaneously with 10  6 Eb, ESb, 
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TABLE  I 
Characteristics of ESb-M Variant Cells in Comparison with Eb and ESb-type Cells 
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Eb  ESb  ESb-M 
Induction  MCA  From Eb in vivo  From ESb in vitro 
Growth in vitro  Suspension  Suspension  Adherent 
Growth in vivo  Large primary (~2 cm ~)  Small primary (~0.5 cm q~)  Large primary (>2 cm ~) 
Metastasis  ±  +++  -+ 
(liver, lung, spleen, etc.) 
TATA expression:  + 
Percent killed by anti-Eb  48,0  3.0  14.2 
CTL  0  58.0  80.0 
Percent killed by anti-ESh 
Expression  of Fe receptor::~ 
Percent positive cells  0  65.0  86.0 
Expression  of differentiation 
antigens:§ 
Thy-1  46.4  7.5  3.3 
Lyt+l  0.2  28.9  82.5 
Lyt-2  37.7  1.0  2.0  *  Tumor-associated transplantation antigens detected by tumor-specific  syngeneic  cytotoxic T lymphocytes (CTL); values 
indicate percent specific SlCr release after 4 h incubation with a 50-fold excess  of effector cells. 
:~ Percent of cells forming rosettes with IgG antibody+coated  erythrocytes. 
§ Percent of cells stained with monoclonal antibodies against the indicated T lymphoid differentiation antigens; results 
from cytofluorographic analysis. 
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FIC.  2.  Histograms from cytofluorographic analysis of tumor cells  stained  with  the  indicated 
FITC-conjugated [ectins (Medac, Hamburg, Federal  Republic of Germany). Background controls 
were done by incubating cells  and lectins in the presence of 0.2  M  inhibitory sugars (GaI-NAe for 
VV, SBA;  D-Gal  for PNA;  o~-methylmannoside for Con A).  3  ×  104 cells  were analyzed for each 
histogram, and the percentage of cells within a region (channel  100-1,000)  is given. Biphasic curves 
(i.e.,  positive and negative cells  within one population) indicate either heterogeneity or cell  cycle 
dependence of lectin receptor sites. 374  FOGEL ET AL.  BRIEF  DEFINITIVE REPORT 
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Fie.  3,  Histograms of tumor cells isolated on day 40 after subcutaneous inoculation of 106 ESb-M 
turn,  or cells from brain (ESb-M-Br) and spleen (ESb-M-Sp). The assay was performed as described 
for Fig. 2. 
cells  were  treated  with  neuraminidase  before  staining,  they  were  found  to  react 
equally well with the lectins SBA, VV, and PNA (Fig.  2). These findings suggest that 
the failure to stain ESb cells was due to a masking of receptor sites by sialic acid. 
The importance of the changes described in terminal carbohydrates between ESb 
and ESb-M was further substantiated by metastatic revertants from ESb-M type cells. 
Rare metastatic revertant tumor cells  could be isolated from the spleen  (ESbM-Sp) 
and brain  (ESbM-Br) of ESb-M tumor-bearing mice 40 d  after tumor inoculation. 
When these revertants were tested  for [ectin binding,  they were found to have lost 
their ability to bind VV and  SBA, whereas the binding of Con A  was unchanged 
(Fig.  3).  Neuraminidase treatment  revealed that the lectin-binding sites were again 
masked by sialic acid  (data  not  shown). These revertant  lines  were  found to  have 
regained the high metastatic capacity characteristic of the parental ESb line and had 
lost their ability to adhere to plastic. 
Discussion 
Previous observations in model systems for metastasis have emphasized the impor- 
tance of cell-surface glycosylation (6, 8)  and of the total amount of cell surface sialic 
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that  the  selection  of a  plastic-adherent  variant  (ESb-M)  from a  highly  metastatic 
mouse tumor line  (ESb)  has  a  greatly decreased metastatic  potential.  The isolation 
procedure is mild,  does not require  mutagenization, and exerts its selection pressure 
by simple in vitro culturing.  The plastic-adherent  variant, although not cloned, was 
stable  over prolonged  periods  of in  vitro  and  in  vivo growth.  Hochman et  al.  (10) 
recently reported on a  plastic-adherent  variant  of a  murine  lymphoma that showed 
increased immunogenicity and impaired  tumorigenicity. ESb-M cells were similar to 
ESb type cells in antigenicity (Table I) and immunogenicity (not shown), but showed 
loss of metastatic  capacity while still  being tumorigenic.  The only major differences 
found between  ESb  and  ESb-M  cells  were  altered  levels  of terminal  sialic  acid  at 
lectin sites for Gal-NAc specific lectins. These changes in sialylation were found to be 
reversed when rare revertants of ESb-M cells, isolated from two distant organs, were 
analyzed. Because uncloned tumor cell populations were studied, we are aware of the 
possibility that  these revertants  could theoretically represent  derivatives  from a  few 
contaminating metastatic ESb cells within the ESb-M cells inoculated. This possibility 
is excluded, however, by the finding that even as many as 107 ESb-M cells inoculated 
intravenously did not give rise to metastases, while as few as  10 ESb cells killed the 
animals within 3 wk after intravenous inoculation (11). 
In a  recent study we have noted similar differences in sialylation as described here 
between  ESb cells and their low metastatic  parental  line Eb. 1 Receptor sites for VV 
and  SBA on  Eb  tumor  cell  were  not  blocked  by sialic  acid  and  could  be  directly 
stained with these lectins in a  specific way. These findings were further corroborated 
in  the  MDAY-D2 tumor system consisting of a  high  metastatic  parental  line,  low- 
metastatic, lectin-resistant  variants, and high-metastatic revertants.  In all cases there 
was a clear correlation between sialic acid content on VV and SBA receptor sites and 
metastatic potential. 
In the Eb/ESb  tumor system, the total amount of cell-surface sialic acid was not 
much different between the two lines. The results from this and other studies therefore 
suggest subtle qualitative changes in the positioning of sialic acid at the cell surface. 
Some sites, like those recognized by lectin-like hepatocyte receptors  (12), seem to be 
sialylated  on  Eb  cells  and  desialylated  on  ESb  cells,  whereas  other  sites,  like  those 
recognized by VV and. SBA lectins, seem to be desialylated on Eb cells and sialylated 
on  ESb-type  cells.  The  possible  transpositioning  of sialic  acid  could  thus  have  a 
double effect, a  decrease of adhesive forces, for instance between tumor cells, and an 
increase of adhesive forces, for example to certain target organ structures. 
We suggest that the expression of certain specific receptor sites by the removal of 
sialic acid alters the tumor cells' adhesive characteristics. The free receptor sites could 
be involved in the adhesiveness of the ESb-M type cells to plastic. Under physiological 
conditions in vivo, such sites could be involved in homotypic (tumor cell-tumor cell) 
adhesion or in the adhesion to host derived cells or their extracellular matrix. 
Summary 
A plastic adherent variant line (ESb-M) of a highly invasive and metastatic murine 
T  cell  lymphoma  (ESb)  was  found  to  have  lost  its  metastatic  potential  while  still 
being tumorigenic in normal syngeneic hosts. The variant  retained  most of its ESb- 
i p. Altevogt, M. Fogel, R. Cheingsong-Popov,  J. Dennis, and V. Schirrmacher. Relayed high and low 
metastatic  mouse tumor  lines shows different patterns  of tectin binding  and  cell surface sialylation. 
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derived antigenic and  biochemical characteristics but  differed  at  binding sites  for 
certain lectins with specificity for terminal N-acetylgalactosamine residues. Whereas 
such sites were masked by sialic acid on metastatic ESb ceils, they became unmasked 
on the adherent variant line. Metastatic revertants of ESb-M cells did not express the 
respective lectin receptor sites because these were again masked by sialic acid. 
It is suggested that  the masking of specific lectin receptor sites on the tumor cell 
surface is of crucial importance for metastatis. If freely exposed, these sites may change 
adherence characteristics of the cells possibly not only in vitro (to plastic) but also in 
vivo. 
We thank Mrs. Kippenhan for excellent graphical assistance. 
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